Category: Publications

SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco

We characterized SARS-CoV-2 infections in a densely-populated, majority Latinx San Francisco community six-weeks into the city’s shelter-in-place order.

17. June 2020

Seroprevalence against COVID-19 and follow-up of suspected cases in primary health care in Spain

During the coronavirus disease 2019 (COVID-19) pandemic little information has been available about patients with mild or moderate symptoms attended and followed in the primary care setting, most of whom had an unknown status for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

16. June 2020

A population-based study of the prevalence of COVID-19 infection in Espirito Santo, Brazil: methodology and results of the first stage

COVID-19 is affecting almost the entire world, causing more than four hundred thousand deaths and undermining the health care systems, as much as the economy, of the afflicted countries.

16. June 2020

Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan -implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

It is to be determined whether people infected with SARS-CoV-2 will develop long-term immunity against SARS-CoV-2 and retain long-lasting protective antibodies after the infection is resolved.

16. June 2020

Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic

Several studies indicated that children seem to be less frequently infected with SARS-CoV-2 and potentially less contagious.

14. June 2020

Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland

The infection fatality risk (IFR) is the average number of deaths per infection by a pathogen and is key to characterizing the severity of infection across the population and for specific demographic groups.

12. June 2020

Antibody response to infectious diseases and other factors accurately predict COVID-19 infection and severity risk 10-14 years later: a retrospective UK Biobank cohort study

Several risk factors have emerged for novel 2019 coronavirus disease (COVID-19) infection and severity.

11. June 2020

Serological Analysis of New York City COVID19 Convalescent Plasma Donors

The development of neutralizing antibodies (NAbs) against SARS-CoV-2, following infection or vaccination, is likely to be critical for the development of sufficient population immunity to drive cessation of the COVID19 pandemic.

9. June 2020

SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study

SARS-CoV-2 infection in Healthcare Workers (HCWs) is a public health concern during the pandemic.

9. June 2020

Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes

A growing body of evidence indicates sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19)1-4.

9. June 2020

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Plattform for seroprevalence studies on SARS-COV-2

Privacy Policy
Impress